CoChat

Brain Activation During Working Memory Is Altered in Patients With Type 1 Diabetes During Hypoglycemia

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To investigate the effects of acute hypoglycemia on working memory and brain function in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: Using blood oxygen level–dependent (BOLD) functional magnetic resonance imaging during euglycemic (5.0 mmol/L) and hypoglycemic (2.8 mmol/L) hyperinsulinemic clamps, we compared brain activation response to a working-memory task (WMT) in type 1 diabetic subjects (n = 16) with that in age-matched nondiabetic control subjects (n = 16). Behavioral performance was assessed by percent correct responses. RESULTS: During euglycemia, the WMT activated the bilateral frontal and parietal cortices, insula, thalamus, and cerebellum in both groups. During hypoglycemia, activation decreased in both groups but remained 80% larger in type 1 diabetic versus control subjects (P < 0.05). In type 1 diabetic subjects, higher HbA1c was associated with lower activation in the right parahippocampal gyrus and amygdala (R2 = 0.45, P < 0.002). Deactivation of the default-mode network (DMN) also was seen in both groups during euglycemia. However, during hypoglycemia, type 1 diabetic patients deactivated the DMN 70% less than control subjects (P < 0.05). Behavioral performance did not differ between glycemic conditions or groups. CONCLUSIONS: BOLD activation was increased and deactivation was decreased in type 1 diabetic versus control subjects during hypoglycemia. This higher level of brain activation required by type 1 diabetic subjects to attain the same level of cognitive performance as control subjects suggests reduced cerebral efficiency in type 1 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db11-0506

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Study protocol. Time line of structural and functional scans, WMTs, and periods of euglycemia (nominal 5.0 mmol/L), glucose descent, and hypoglycemia (nominal 2.8 mmol/L).
FIG. 1. Study protocol. Time line of structural and functional scans, WMTs, and periods of euglycemia (nominal 5.0 mmol/L), glucose descent, and hypoglycemia (nominal 2.8 mmol/L).CC BY-NC-ND · PubMed Central
FIG. 2. Plasma levels of counterregulatory hormones (error bars ± SE) during the baseline and euglycemic periods and at the end of the hypoglycemic period in control subjects and patients with type 1 diabetes (T1DM). EU, euglycemia; HYPO, hypoglycemia. P values for statistically significant comparisons: *P < 0.05 vs. baseline; †P < 0.05 vs. euglycemia; ‡P < 0.01 vs. baseline; §P < 0.01 vs. euglycemia; •P < 0.05 vs. control subjects; ¶P < 0.001 vs. control subjects.
FIG. 2. Plasma levels of counterregulatory hormones (error bars ± SE) during the baseline and euglycemic periods and at the end of the hypoglycemic period in control subjects and patients with type 1 diabetes (T1DM). EU, euglycemia; HYPO, hypoglycemia. P values for statistically significant comparisons: *P < 0.05 vs. baseline; †P < 0.05 vs. euglycemia; ‡P < 0.01 vs. baseline; §P < 0.01 vs. euglycemia; •P < 0.05 vs. control subjects; ¶P < 0.001 vs. control subjects.CC BY-NC-ND · PubMed Central
FIG. 3. BOLD activation during the WMT in control and type 1 diabetic (T1DM) subjects during euglycemia and hypoglycemia. Statistical parametric maps of regions of greatest activation during WMTs vs. control tasks for each subject group and glycemic condition. Functional activations (red-to-yellow color scale) are overlaid on the MNI-152 standard brain anatomy (gray scale). The threshold for activation was P < 0.05 after correction for multiple comparisons using the cluster-based threshold method (see research design and methods). During hypoglycemia, type 1 diabetic subjects exhibit greater activation than control subjects during the WMT. (A high-quality digital representation of this figure is available in the online issue.)
FIG. 3. BOLD activation during the WMT in control and type 1 diabetic (T1DM) subjects during euglycemia and hypoglycemia. Statistical parametric maps of regions of greatest activation during WMTs vs. control tasks for each subject group and glycemic condition. Functional activations (red-to-yellow color scale) are overlaid on the MNI-152 standard brain anatomy (gray scale). The threshold for activation was P < 0.05 after correction for multiple comparisons using the cluster-based threshold method (see research design and methods). During hypoglycemia, type 1 diabetic subjects exhibit greater activation than control subjects during the WMT. (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 4. Percent BOLD activation by ROI analysis during the WMT during euglycemia (left) and hypoglycemia (right). Upper: Location of the superior parietal lobule (SPL, association cortex including Brodmann areas 7 and 40) region used for ROI analysis is indicated at the intersection of the crosshairs on the activation maps for each subject group overlaid on the MNI-152 standard brain. Lower: Plots of the time courses of change in percent BOLD activation in the SPL ROI during the fMRI WMT. Percent change was measured relative to BOLD activation during the control task and averaged over all pixels in the ROI and all subjects within each subject group. The colored strip above the horizontal time axis shows the time sequence of task conditions. CONT, control task; REST, resting state task. (A high-quality digital representation of this figure is available in the online issue.)
FIG. 4. Percent BOLD activation by ROI analysis during the WMT during euglycemia (left) and hypoglycemia (right). Upper: Location of the superior parietal lobule (SPL, association cortex including Brodmann areas 7 and 40) region used for ROI analysis is indicated at the intersection of the crosshairs on the activation maps for each subject group overlaid on the MNI-152 standard brain. Lower: Plots of the time courses of change in percent BOLD activation in the SPL ROI during the fMRI WMT. Percent change was measured relative to BOLD activation during the control task and averaged over all pixels in the ROI and all subjects within each subject group. The colored strip above the horizontal time axis shows the time sequence of task conditions. CONT, control task; REST, resting state task. (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 5. BOLD activation and deactivation during the WMT in type 1 diabetic (T1DM) and control subjects during euglycemia and hypoglycemia. Statistical parametric maps of regions of greatest activation during WMTs vs. control tasks (functional activations in the red-to-yellow color scale) and regions of decreased activation during the WMTs vs. resting tasks (functional deactivations in the blue color scale) are overlaid on the MNI-152 standard brain anatomy (gray scale). The threshold for activations and deactivations was P < 0.05 after correction for multiple comparisons using the cluster-based threshold method (see research design and methods). During hypoglycemia, patients with type 1 diabetes exhibit less deactivation than control subjects. (A high-quality digital representation of this figure is available in the online issue.)
FIG. 5. BOLD activation and deactivation during the WMT in type 1 diabetic (T1DM) and control subjects during euglycemia and hypoglycemia. Statistical parametric maps of regions of greatest activation during WMTs vs. control tasks (functional activations in the red-to-yellow color scale) and regions of decreased activation during the WMTs vs. resting tasks (functional deactivations in the blue color scale) are overlaid on the MNI-152 standard brain anatomy (gray scale). The threshold for activations and deactivations was P < 0.05 after correction for multiple comparisons using the cluster-based threshold method (see research design and methods). During hypoglycemia, patients with type 1 diabetes exhibit less deactivation than control subjects. (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 6. Regions of BOLD activation inversely correlated with HbA1c in patients with type 1 diabetes. Upper: Statistical parametric map of the correlation of WMT activation with HbA1c in patients with type 1 diabetes during hypoglycemia (P < 0.05). Sagittal, coronal, and axial slices (from left to right) showing activation correlation in a red-to-yellow scale overlaid on the MNI-152 standard brain anatomy (gray scale). These HbA1c-correlated activation clusters were identified in the right parahippocampal gyrus and amygdala using the Harvard-Oxford Cortical Structural Atlas. Lower: Plots of regional percent BOLD activation vs. HbA1c for patients with type 1 diabetes during euglycemia (left) and hypoglycemia (right). Filled circles with error bars: average percent BOLD activation for each patient ± SD within the region of activation. The line is the linear regression best fit of the data with its correlation coefficient R2. (A high-quality digital representation of this figure is available in the online issue.)
FIG. 6. Regions of BOLD activation inversely correlated with HbA1c in patients with type 1 diabetes. Upper: Statistical parametric map of the correlation of WMT activation with HbA1c in patients with type 1 diabetes during hypoglycemia (P < 0.05). Sagittal, coronal, and axial slices (from left to right) showing activation correlation in a red-to-yellow scale overlaid on the MNI-152 standard brain anatomy (gray scale). These HbA1c-correlated activation clusters were identified in the right parahippocampal gyrus and amygdala using the Harvard-Oxford Cortical Structural Atlas. Lower: Plots of regional percent BOLD activation vs. HbA1c for patients with type 1 diabetes during euglycemia (left) and hypoglycemia (right). Filled circles with error bars: average percent BOLD activation for each patient ± SD within the region of activation. The line is the linear regression best fit of the data with its correlation coefficient R2. (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 72

Metadata

Authors
Bolo, N. R., Musen, G., Jacobson, A. M., Weinger, K., McCartney, R. L., Flores, V., Renshaw, P. F., & Simonson, D. C.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • Joslin Diabetes Center (US)
  • Winthrop-University Hospital (US)
  • Harvard University (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Bolo, Nicolas R.
Venue
Diabetes
Published
2011-11-13
Volume
60
Issue
12
Pages
3256-3264
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2153793093
Cited by
72
References
52
Citations by year
2026: 10 · 2024: 8 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 5
FWCI
4.99
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • American Diabetes Association
  • Brigham and Women's Hospital
  • Joslin Diabetes Center
  • National Institutes of Health (5r01dk073843-03, DK 36836)
  • National Institute on Drug Abuse (K05DA031247)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK073843, P30-DK36836, R01DK060754, DK60754, DK-62218-01A1, 5R01-DK073843-03, R01DK062218, P30DK036836)
  • National Center for Research Resources (M01RR001032, 5M01-RR001032-32)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Clinical Neurology › Neurological and metabolic disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
type 1 diabetes, hypoglycemia, working memory, brain activation, hyperinsulinemic-euglycemic clamp, default mode network, HbA1c, parahippocampal gyrus, amygdala, cognitive performance
MeSH terms
Adult, Blood Glucose, Brain, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemia, Magnetic Resonance Imaging, Male, Memory, Short-Term, Middle Aged, Case-Control Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.